Publicacions en col·laboració amb investigadors/es de Pfizer (United States) (8)

2024

  1. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey

    Journal of Headache and Pain, Vol. 25, Núm. 1

2020

  1. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

    Contemporary Clinical Trials, Vol. 98

2007

  1. Effects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease

    American Journal of Cardiology, Vol. 99, Núm. 7, pp. 903-905

2006

  1. Effects of statins on bone markers bone mineral density and fractures. Possible role in osteoporosis treatment

    Current Pharmaceutical Analysis, Vol. 2, Núm. 2, pp. 161-168

2005

  1. Effect of atorvastatin to RANKL/OPG system in patients with acute coronary syndrome

    Journal of Applied Research, Vol. 5, Núm. 4, pp. 569-574

2003

  1. Bone mass and bone modelling markers in hypertensive postmenopausal women

    Journal of Human Hypertension, Vol. 17, Núm. 2, pp. 107-110

  2. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: Relationship with angiotensin converting enzyme polymorphisms

    American Journal of Hypertension, Vol. 16, Núm. 6, pp. 453-459

  3. Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women

    American Journal of Hypertension, Vol. 16, Núm. 3, pp. 233-235